Abstract
IntroductionDiabetic sensorimotor polyneuropathy (DSPN) affects approximately 30% of people with diabetes, while around half of cases are symptomatic. Currently, there are only few pathogenetically oriented pharmacotherapies for DSPN, one of...
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have